Here, to determine the absolute requirement for the FN-integrin interactions in tumor angiogenesis, we used genetic tools to remove the FN-binding integrin subunits α5 and αv from the endothelium, prior to tumor growth, in two transplant models and the RIP-Tag model of angiogenesis-dependent pancreatic cancer. The gene discussed is FN1; the disease is neoplasm.